HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Nephrocardiology
Nephrocardiology
Nephrocardiology sometimes also called cardionephrology, the study deals with cardiorenal syndromes and cardiac complications. It is a subspecialty that addresses the interaction and mechanisms that are not well addressed in either of the earlier specialties. Patients with cardiovascular disease have one or more nephrology-related conditions, which may be undiagnosed. These comorbidities require further study with respect to pathophysiology, their diagnosis, prognosis, evaluation, Prevention, therapy, adverse reactions, and the systemic diseases that involve both nephrology-related conditions and cardiovascular diseases.
Committee Members
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Filippo Crea
Catholic University of the Sacred Heart, Italy Heart Congress 2025 Speakers
Federico Benetti
Benetti Foundation, Argentina
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Miroslav Radenkovic
University of Belgrade, SerbiaSubmit your abstract Today
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Back to basics: The pharmacokinetics of direct oral anticoagulants in short-gut syndrome
Abhishek Chandra, Abbott Northwestern Hospital, United States
Title : Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia